Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.President of STELLANTIS Europe: If you want to avoid EU fines in 2025, you should either increase the sales of electric vehicles or reduce the production of gasoline vehicles.At least 15 people were killed and 64 injured in the attack on the capital of Northern Darfur, Sudan. According to the Sudan Tribune, the Sudan Rapid Support Force shelled a livestock market and Zam Zam refugee camp in the south of El Fasher on the 11th local time, killing at least 15 people and injuring 64 others, including 10 women and 5 children. (Zhongxin. com)
The International Finance Corporation (IFC) and HSBC signed a $1 billion trade flow arrangement for emerging markets.CEO of STELLANTIS Europe: We will never pay a fine for the EU emission reduction requirements in 2025, and we are ready to reduce production to avoid this situation.The US dollar just hit the 7.2700 yuan mark against the offshore RMB, and the latest price was 7.2700 yuan, down 0.10% in the day. The US dollar against the onshore RMB was recently reported at 7.2660 yuan, up 0.06% in the day.
Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.Morgan Stanley lowered Macy's target price from $17.00 to $16.00.Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.
Strategy guide 12-13
Strategy guide 12-13